The company is preparing a dual FDA 510(k) and CLIA Waiver submission for its Flu A/B and RSV multiplex test on the Co-Dx PCR Pro platform....
A blood test for Alzheimer's disease biomarkers helped improve diagnostic accuracy among specialists and primary care physicians in a real-world study...
The Xpert Xpress MVP test helped more women receive appropriate treatment within 24 hours compared with usual diagnostic methods....
CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline across Europe...
The platform was built and validated specifically for dogs, and LatusPet plans to add further conditions each year, with work underway to extend it to other species...
To develop the new feline quality of life (FelQoL) questionnaire, the researchers used data from 1,324 cat owners in the United States and the United Kingdom...
New findings show hair loss affecting more young people in APAC...
Alongside its strategic investment, Shrem will also partner with Emoha to establish Shremoha...
First and only melanoma gene expression profiling test that is both designated as an FDA Breakthrough Device and included in the NCCN guidelines for T1b and T2a cutaneous melanoma patients...
The two ProteusONE systems will be the first proton therapy systems in the country and will serve as the National Proton Therapy Centre of Portugal...
